Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)
Bangladesh
· Delayed Price · Currency is BDT 752.70
-5.20 (-0.69%)
At close: Apr 28, 2026
Ambee Pharmaceuticals Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | 6.6 | 5.31 | 9.68 | 9.09 | 8.06 | -13.01 | Upgrade
|
| Depreciation & Amortization | 7.23 | 5.51 | 6.05 | 7.54 | 6.05 | 6.92 | Upgrade
|
| Other Operating Activities | 52.33 | 0 | -0 | -37.09 | -0.09 | -0.32 | Upgrade
|
| Change in Accounts Receivable | -31.72 | -14.19 | -45.63 | -23.43 | -20.28 | -23.08 | Upgrade
|
| Change in Inventory | -29.21 | 11.11 | -24.67 | -18.36 | -50 | 31.37 | Upgrade
|
| Change in Accounts Payable | 0.29 | 0.54 | 0.61 | -1.57 | -0.67 | -2.84 | Upgrade
|
| Change in Income Taxes | -7.57 | -7.27 | -9.71 | 22.13 | -2.75 | 1.05 | Upgrade
|
| Change in Other Net Operating Assets | 22.3 | 20.72 | -2.26 | 6.46 | -13.51 | -5.54 | Upgrade
|
| Operating Cash Flow | 20.25 | 21.73 | -65.92 | -35.23 | -73.18 | -5.45 | Upgrade
|
| Capital Expenditures | -14.99 | -23.79 | -2.2 | -0.11 | -1.53 | - | Upgrade
|
| Investment in Securities | -65.66 | -152.6 | - | - | - | - | Upgrade
|
| Other Investing Activities | 0.06 | 0.06 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -80.6 | -176.34 | -2.2 | -0.11 | -1.53 | - | Upgrade
|
| Short-Term Debt Issued | - | 161.94 | 81.82 | 101.48 | 132.69 | 10.62 | Upgrade
|
| Long-Term Debt Issued | - | - | 0.71 | - | - | - | Upgrade
|
| Total Debt Issued | 31.99 | 161.94 | 82.53 | 101.48 | 132.69 | 10.62 | Upgrade
|
| Short-Term Debt Repaid | - | - | -11.48 | -52.54 | -51.56 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.4 | - | -0.96 | -3.09 | -0.87 | Upgrade
|
| Total Debt Repaid | -0.56 | -0.4 | -11.48 | -53.5 | -54.65 | -0.87 | Upgrade
|
| Net Debt Issued (Repaid) | 31.42 | 161.54 | 71.05 | 47.98 | 78.04 | 9.76 | Upgrade
|
| Common Dividends Paid | -2.14 | -2.35 | -3.38 | -1 | -1.5 | -0.33 | Upgrade
|
| Other Financing Activities | -4.62 | -4.62 | 4.62 | - | - | - | Upgrade
|
| Financing Cash Flow | 24.66 | 154.56 | 72.3 | 46.98 | 76.54 | 9.43 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0.06 | -0.06 | - | 0 | - | - | Upgrade
|
| Net Cash Flow | -35.75 | -0.1 | 4.17 | 11.64 | 1.83 | 3.98 | Upgrade
|
| Free Cash Flow | 5.25 | -2.06 | -68.12 | -35.34 | -74.71 | -5.45 | Upgrade
|
| Free Cash Flow Margin | 2.86% | -0.89% | -31.06% | -17.84% | -41.28% | -5.51% | Upgrade
|
| Free Cash Flow Per Share | 2.19 | -0.86 | -28.39 | -14.72 | -31.13 | -2.27 | Upgrade
|
| Cash Interest Paid | 0.35 | 0.39 | 1.93 | 3.69 | 5.77 | 5.82 | Upgrade
|
| Cash Income Tax Paid | 5.36 | 5.5 | 14.49 | 15.47 | 5.85 | -31.12 | Upgrade
|
| Levered Free Cash Flow | -1.32 | -483.28 | 400.07 | 1.12 | -104.8 | -2.47 | Upgrade
|
| Unlevered Free Cash Flow | -1.28 | -483.22 | 400.43 | 2.68 | -101.91 | 0.65 | Upgrade
|
| Change in Working Capital | -45.91 | 10.91 | -81.65 | -14.77 | -87.21 | 0.96 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.